Epidemiology of childhood leukemia in Mexico and Latin America: Effects of vulnerability and social justice
Main Article Content
Keywords
Leukemia, Epidemiology, Child Health, Social Vulnerability, Health Inequities
Abstract
Acute leukemia (AL) is the most common malignancy in children in Mexico and Latin America, where high incidence and mortality rates are observed, particularly among populations with indigenous ancestry and unfavorable socioeconomic conditions. This article examines the social and biological determinants that influence the onset and progression of acute lymphoblastic leukemia (ALL), highlighting the Greaves and Kinlen hypotheses and their potential relevance in Latin American contexts. Evidence suggests that factors such as poverty, educational disadvantage, overcrowding, and limited access to healthcare directly affect childhood mortality from AL. In the analysis conducted specifically for this study, using publicly available open-access databases, a poverty-mortality gradient was identified, showing that the poorest municipalities face a higher risk of leukemia-related death in individuals under 20 years of age. The study concludes that epidemiology, when integrated with principles of social justice, is essential for designing and monitoring public policy interventions aimed at reducing inequalities and improving childhood survival in Mexico.
References
1. BMJ. Acute lymphoblastic leukaemia - Symptoms, diagnosis and treatment | BMJ Best Practice; 2024. Disponible en: https://bestpractice-bmj-com.pbidi.unam.mx:2443/topics/en-gb/273
2. Buser JM, Lake K, Ginier E. Environmental Risk Factors for Childhood Cancer in an Era of Global Climate Change: A Scoping Review. Journal of Pediatric Health Care. 2022;36(1):46-56. doi: 10.1016/j.pedhc.2021.05.005
3. International Agency for Research on Cancer (IARC). Globocan; 2022. Disponible en: https://gco.iarc.fr/en
4. Wilkinson JD, Fleming LE, MacKinnon J, et al. Lymphoma and lymphoid leukemia incidence in Florida children. Cancer. 2001;91(7):1402-8. doi: 10.1002/1097-0142(20010401)91:7<1402::AID-CNCR1145>3.0.CO;2-6
5. Quiroz E, Aldoss I, Pullarkat V, et al. The emerging story of acute lymphoblastic leukemia among the Latin American population – biological and clinical implications. Blood Rev. 2019;33:98-105. doi: 10.1016/j.blre.2018.08.002
6. Erdmann F, Li T, Luta G, et al. Incidence of childhood cancer in Costa Rica, 2000–2014: An international perspective. Cancer Epidemiol. 2018;56:21-30. doi: 10.1016/j.canep.2018.07.004
7. Steliarova-Foucher E, Colombet M, Ries L, et al. International incidence of childhood cancer, 2001–2010: a population-based registry study. Lancet Oncol. 2017;18(6):719-31. doi: 10.1016/S1470-2045(17)30186-9
8. Silva-Junior AL, Alves FS, Kerr MWA, et al. Acute lymphoid and myeloid leukemia in a Brazilian Amazon population: Epidemiology and predictors of comorbidity and deaths. PLoS ONE. 2019;14(8): e0221518. doi: 10.1371/journal. pone.0221518
9. Flores-Lujano J, Duarte-Rodríguez DA, Jiménez-Hernández E, et al. Persistently high incidence rates of childhood acute leukemias from 2010 to 2017 in Mexico City: A population study from the MIGICCL. Front Public Health. 2022;10:2933. doi: 10.3389/FPUBH.2022.918921/BIBTEX
10. Pérez-Saldivar ML. Childhood acute leukemias are frequent in Mexico City: descriptive epidemiology. BMC Cancer. 2011;11(1):1-11. doi:10.1186/1471-2407-11-355
11. Mejía-Aranguirre JM. Incidence of leukemias in children from El Salvador and Mexico City between 1996 and 2000: Population-based data. BMC Cancer. 2005;5. doi: 10.1186/1471-2407-5-33
12. Fajardo-Gutiérrez A, González-Miranda G, Pachuca-Vázquez A, et al. Cancer incidence and mortality in children in the Mexican Social Security Institute (1996-2013). Salud Publica Mex. 2016;58(2). Disponible en: https://saludpublica.mx/index.php/spm/article/view/7785/10603
13. Fajardo-Gutiérrez A, Juárez-Ocaña S, González-Miranda G, et al. Incidence of cancer in children residing in ten jurisdictions of the Mexican Republic: Importance of the Cancer registry (a population-based study). BMC Cancer. 2007;7(1):1-15. doi: 10.1186/1471-2407-7-68/TABLES/6
14. Mejía-Aranguré JM. Molecular epidemiology of acute leukemia in children: causal model, interaction of three factors—susceptibility, environmental exposure and vulnerability period. Boletín Médico del Hospital Infantil de México (English Edition). 2016;73(1):55-63. doi: 10.1016/S2444-3409(16)30019-X
15. Morris JA. The age incidence of childhood acute lymphoblastic leukaemia. Med Hypotheses. 1991;35(1):4-10. doi: 10.1016/0306-9877(91)90075-A
16. Mejía-Aranguré JM. Model for the Origin of Acute Leukemias in Children: Interaction of Three Factors—Susceptibility, Exposure, and Window of Vulnerability. Etiology of Acute Leukemias in Children. 2016;18:133-55. doi: 10.1007/978-3-319-05798-9_6
17. Juárez-Ocaña S, González-Miranda G, Mejía-Aranguré JM, et al. Frequency of cancer in children residing in Mexico City and treated in the hospitals of the Instituto Mexicano del Seguro Social (1996–2001). BMC Cancer. 2004;4:50. doi: 10.1186/1471-2407-4-50
18. Mejía-Aranguré JM, Pérez-Saldivar ML, Flores-Lujano J, et al. Infections and Acute Leukemia in Children with Down Syndrome. Prenatal Diagnosis and Screening for Down Syndrome. 2011. doi: 10.5772/18533
19. Arellano-Galindo J, Barrera AP, Jiménez-Hernández E, et al. Infectious Agents in Childhood Leukemia. Arch Med Res. 2017;48(4):305-13. doi: 10.1016/J.ARCMED.2017.09.001
20. Flores-Lujano J, Perez-Saldivar ML, Fuentes-Pananá EM, et al. Breastfeeding and early infection in the aetiology of childhood leukaemia in down syndrome. Br J Cancer. 2009;101(5):860-4. doi: 10.1038/sj.bjc.6605244
21. Mata-Rocha M, Rangel-López A, Jimenez-Hernandez E, et al. Low Prevalence of ETV6::RUNX1 Fusion Gene in a Hispanic Population. Front Pediatr. 2022;10. doi: 10.3389/fped.2022.837656
22. Mejía-Arangure JM, Model for Identifying the Etiology of Acute Lymphoblastic Leukemia in Children. In: Mejía-Arangure JM, ed. Clinical Epidemiology of Acute Lymphoblastic Leukemia - From the Molecules to the Clinic. 2013. doi:10.5772/52716
23. Schmiegelow K, Vestergaard T, Nielsen SM, et al. Etiology of common childhood acute lymphoblastic leukemia: the adrenal hypothesis. Leukemia;22(12):2137-41. doi: 10.1038/leu.2008.212
24. Bonita R, Beaglehole R, Kjellström T. Epidemiología básica. Washington, DC: Organización Panamericana de la Salud; 2008. Disponible en: https://iris.paho.org/handle/10665.2/3153
25. Boutain DM. Social justice as a framework for undergraduate community health clinical experiences in the United States. Int J Nurs Educ Scholarsh. 2008;5(1). doi: 10.2202/1548-923X.1419
26. Redman RW, Clark L. Service-learning as a model for integrating social justice in the nursing curriculum. J Nurs Educ. 2002;41(10):446-9. doi: 10.3928/0148-4834-20021001-08
27. World Health Organization. Health is a Fundamental Right. Geneva: WHO; December 10, 2017. Disponible en: https://www.who.int/news-room/commentaries/detail/health-is-a-fundamental-human-right
28. Eden T, Pui CH, Schrappe M, et al. All children have a right to full access to treatment for cancer [2]. Lancet. 2004;364(9440):1121-2. doi: 10.1016/S0140-6736(04)17089-X
29. La Vecchia C, Levi F, Lucchini F, et al. Trends in childhood cancer mortality as indicators of the quality of medical care in the developed world. Cancer. 1998;83(10):2223-7.
30. Hall JE, Moonesinghe R, Bouye K, et al. Racial/Ethnic Disparities in Mortality: Contributions and Variations by Rurality in the United States, 2012–2015. International Journal of Environmental Research and Public Health. 2019;16(3):436. doi: 10.3390/IJERPH16030436
31. Instituto Nacional de Estadística y Geografía. Estadísticas de Defunciones Registradas (EDR). Disponible en: https://www.inegi.org.mx/programas/edr/
32. Consejo Nacional de Población. Reconstrucción y proyecciones de la población de los municipios de México (1990–2020, proyecciones 2021–2040). Ciudad de México: CONAPO; 9 de mayo de 2024. Disponible en: https://www.gob.mx/cms/uploads/attachment/file/918028/BD_municipales_portada_regiones_FINAL.pdf
33. Consejo Nacional de Evaluación de la Política de Desarrollo Social. Informe de Evaluación de la Política de Desarrollo Social 2020. Ciudad de México: CONEVAL; 2021. Disponible en: https://www.coneval.org.mx/EvaluacionDS/PP/IEPDS/Documents/IEPDS_2020_Presentacion.pdf
34. Ribeiro AI, Fecht D. Environmental Determinants of the Social Gradient in Cancer Incidence. in G Launoy, V Zadnik & MP Coleman (eds), Social Environment and Cancer in Europe: Towards an Evidence-Based Public Health Policy. Springer. 2021. pp. 221-33.
35. Bentham J, Di Cesare M, Bilano V, et al. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet. 2017;390(10113):2627-42. doi: 10.1016/S0140-6736(17)32129-3
36. Flores-Lujano J, Allende-López A, Duarte-Rodríguez DA, et al. Epidemiology of childhood acute leukemias in marginalized populations of the central-south region of Mexico: results from a population-based registry. Front Oncol. 2024;14. doi: 10.3389/FONC.2024.1304263
37. Karim-Kos HE, Hackl M, Mann G, et al. Trends in incidence, survival and mortality of childhood and adolescent cancer in Austria, 1994-2011. Cancer Epidemiol. 2016;42:72-81. doi: 10.1016/j.canep.2016.03.015
38. Núñez-Enríquez JC, Romo-Rodríguez R, Gaspar-Mendoza P, et al. Implementation of a roadmap for the comprehensive diagnosis, follow-up, and research of childhood leukemias in vulnerable regions of Mexico: results from the PRONAII Strategy. Front Oncol. 2024;14:1304690. doi: 10.3389/fonc.2024.1304690
39. Alfaro-Hernández L, Ramírez-Ramírez D, Romo-Rodríguez R, et al. Impact of standardized immunophenotyping and MRD monitoring on early mortality reduction in childhood leukemia: a step towards addressing healthcare disparities in vulnerable populations from Southern Mexico. Front Oncol. 2025;15:1614445. doi: 10.3389/fonc.2025.1614445
Article Sidebar
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors retain their copyright and grant the Revista Médica del IMSS the right of first publication. Articles are distributed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which allows sharing as long as the author and the original source are properly credited.